Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong
· Delayed Price · Currency is HKD 17.18
-0.20 (-1.15%)
Apr 29, 2026, 4:08 PM HKT
Qyuns Therapeutics Market Cap
Qyuns Therapeutics has a market cap or net worth of 3.90 billion as of April 29, 2026. Its market cap has increased by 93.14% in one year.
Market Cap
3.90B
Enterprise Value
3.37B
Revenue
897.99M
Ranking
n/a
PE Ratio
11.11
Stock Price
17.18
Market Cap Chart
Since March 20, 2024, Qyuns Therapeutics's market cap has decreased from 5.02B to 3.90B, a decrease of -22.19%. That is a compound annual growth rate of -11.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.90B | -7.86% |
| Dec 31, 2025 | 4.24B | 158.47% |
| Dec 31, 2024 | 1.64B | -67.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TYK Medicines | 3.89B |
| BioDlink International Company | 3.77B |
| Clover Biopharmaceuticals | 3.71B |
| Mirxes Holding Company | 3.66B |
| Viva Biotech Holdings | 3.61B |
| Shandong Boan Biotechnology | 4.24B |
| Antengene Corporation | 3.44B |
| Jiangsu Recbio Technology | 3.13B |